MAR 08, 2016 08:58 AM PST

Scientists build a placenta to study infections like Zika

4 11 2791
A new cell-based model of the human placenta could help explain how pathogens cross from mother to unborn child.

The researchers are beginning to use their model to test whether Zika virus, and other pathogens associated with congenital disease, can infect placental cells and/or cross the placental barrier.

“The human placenta is unique and unlike that of other many other placental mammals,” says Carolyn Coyne, ssociate professor of microbiology and molecular genetics at the University of Pittsburgh School of Medicine. “With our new model in the research toolkit, we and other scientists hope to advance our knowledge of the placenta, examine its function, and learn how it can prevent most, but not all, maternal infections from causing problems for the baby.”
 
With the help of a microgravity chamber, scientists developed a 3D model of the placenta to learn more about how infectious agents can cross from mother to unborn child.

Researchers currently can obtain and study placental cell lines, but such cells do not fuse spontaneously to form the characteristic structure of the human organ. Some scientists study cells, called primary human trophoblasts, that are isolated from placentas obtained after childbirth, but such cells do not divide, can be more difficult to obtain, and are more difficult to genetically manipulate to learn about biochemical pathways that have a role in placental function, says Coyne, senior investigator of the study published in Science Advances.
 

A different approach


Coyne’s team cultured a human placental trophoblast cell line in a microgravity bioreactor system developed by NASA. The trophoblasts along with blood vessel cells were added to small dextran beads that were then spun around in a container filled with cell culture fluid, creating shear stress and rotational forces to better mimic the environment at the maternal-fetal interface than static cell-culture systems.

As a result, the cells fused to form syncytiotrophoblasts, and thus more closely resemble the primary cells lining the outermost layer of the tree-like or villous structure of the human placental tissue.

Next, the researchers tested the functional properties of their model by exposing it to a virus and to Toxoplasma gondii, a parasite found in cat feces that can lead to fetal infection, causing miscarriage, congenital disease, and/or disability later in life.

“We found that the syncytiotrophoblasts formed in our system recapitulated the barrier properties of the naturally occurring cells and they resisted infection by a model virus and three genetically different strains of Toxoplasma,” says Jon P. Boyle, co-investigator and associate professor of biological sciences. “With this model, we can experiment with different biological factors to see what might allow an infectious agent to get through the placental barrier to the fetus.”

He says understanding the placenta might one day lead to ways to prevent fetal damage from the so-called TORCH infections: toxoplasmosis, rubella, cytomegalovirus, herpes, and HIV.

Additional researchers from the University of Pittsburgh, Arizona State University, and Johns Hopkins University contributed to the research, which was funded by the National Institutes of Health and the Burroughs Wellcome Fund.

Source: University of Pittsburgh

This article was originally posted on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
JUN 05, 2018
Technology
JUN 05, 2018
Bacteria Capsule Finds Stomach Bleeding, Alerts Smartphone
MIT Smart Bacteria Sensor Hunts for Stomach Bleeding
JUN 10, 2018
Microbiology
JUN 10, 2018
Killer Antibiotic-resistant Pathogen Isolated in the US
For decades, people have relied on antibiotics to treat microbial infections, but that is changing.
JUN 13, 2018
Immunology
JUN 13, 2018
Vitamin A Gives Immune System Power to Fight Tuberculosis
Multidrug-resistant tuberculosis bacteria are a serious health concern for the global population, but a new finding offers a new therapeutic solution that
JUN 27, 2018
Cancer
JUN 27, 2018
Engineered Poliovirus in Clinical Trials for Glioblastoma
Glioblastoma is a very difficult cancer to treat; researchers look to an engineered poliovirus for novel targeted approach for grade IV patients.
AUG 04, 2018
Microbiology
AUG 04, 2018
The Viral Link to Irritable Bowel Disease
We now know of the importance of the microbiome, but most of the research focus has been on bacteria.
AUG 13, 2018
Genetics & Genomics
AUG 13, 2018
A Kind of Forensics to ID the Source of Bacterial Outbreaks
Scientists at Mayo Clinic have developed a way to use whole genome sequencing to locate the source of deadly bacterial pathogens.
Loading Comments...